
Group 1 - ClearPoint Neuro, Inc. (CLPT) shares have increased by 18.2% over the past four weeks, closing at $13.64, with a mean price target of $27.67 indicating a potential upside of 102.9% [1] - The average price targets range from a low of $25 to a high of $30, with a standard deviation of $2.52, suggesting a potential increase of 83.3% to 119.9% from the current price level [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, indicating a positive outlook for CLPT [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 0.8% over the last 30 days, with one estimate moving higher and no negative revisions [12] - CLPT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movements [10][13]